VIEKIRA XR(dasabuvir, ombitasvir, paritaprevir, and ritonavir)extended-release tablets(三十九)
Rx only
viekira XR™
(dasabuvir, ombitasvir, paritaprevir, and ritonavir) extended-release tablets
200 mg/8.33 mg/50 mg/33.33 mg
Each VIEKIRA XR tablet contains 200 mg of dasabuvir equivalent to
216.2 mg of dasabuvir sodium monohydrate, 8.33 mg of ombitasvir,
50 mg of paritaprevir, and 33.33 mg of ritonavir
Do not split, crush or chew tablets
This carton contains 21 Tablets packaged as follows:
7 wallets for 1 week of treatment. Each wallet contains 3 tablets.
Do not use if seal on top of carton is broken or missing
Keep out of reach of children
Store at or below 30°C (86°F)
See Package Insert for full Prescribing Information
AbbVie Inc.
North Chicago, IL 60064
©2016 AbbVie Inc.
viekira xr weekly wallet
NDC 0074-0063-01
Rx only
viekira XR™
(dasabuvir, ombitasvir, paritaprevir, and ritonavir)
extended-release tablets
200 mg/8.33 mg/50 mg/33.33 mg
Each VIEKIRA XR tablet contains 200 mg of dasabuvir equivalent
to 216.2 mg of dasabuvir sodium monohydrate, 8.33 mg of ombitasvir,
50 mg of paritaprevir, and 33.33 mg of ritonavir
Do not split, crush or chew tablets
Each box contains: 1 wallet of 3 tablets each
Keep out of reach of children
Store at or below 30°C (86°F)
See Package Insert for full Prescribing Information
AbbVie Inc.
North Chicago, IL 60064
Product of Ireland
©2016 AbbVie Inc.
1 day replacement pak
INGREDIENTS AND APPEARANCE
VIEKIRA XR
dasabuvir and ombitasvir and paritaprevir and ritonavir kit
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:0074-0063
Packaging
# Item Code Package Description Marketing Start Date Marketing End Date
1 NDC:0074-0063-28 4 in 1 CARTON 07/22/2016
1 7 in 1 CARTON
1 1 in 1 DOSE PACK; Type 0: Not a Combination Product
2 NDC:0074-0063-01 1 in 1 CARTON 07/22/2016
2 1 in 1 DOSE PACK; Type 0: Not a Combination Product
Quantity of Parts
Part # Package Quantity Total Product Quantity
Part 1 2
Part 1 of 1
TRADENAME XR
dasabuvir and ombitasvir and paritaprevir and ritonavir tablet, film coated
Product Information
Route of Administration ORAL
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
RITONAVIR (UNII: O3J8G9O825) (RITONAVIR - UNII:O3J8G9O825) RITONAVIR 33.33 mg
DASABUVIR SODIUM MONOHYDRATE (UNII: OG6D40M62L) (DASABUVIR - UNII:DE54EQW8T1) DASABUVIR 200 mg
PARITAPREVIR DIHYDRATE (UNII: HRQ5901O78) (PARITAPREVIR - UNII:OU2YM37K86) PARITAPREVIR 50 mg
OMBITASVIR HEMINONAHYDRATE (UNII: EQE3I70J3W) (OMBITASVIR - UNII:2302768XJ8) OMBITASVIR 8.33 mg
Inactive Ingredients
Ingredient Name Strength
COPOVIDONE K25-31 (UNII: D9C330MD8B)
SILICON DIOXIDE (UNII: ETJ7Z6XBU4)
TALC (UNII: 7SEV7J4R1U)
TITANIUM DIOXIDE (UNII: 15FIX9V2JP)
POLYETHYLENE GLYCOL 3350 (UNII: G2M7P15E5P)
SORBITAN MONOLAURATE (UNII: 6W9PS8B71J)
TOCOPHERSOLAN (UNII: O03S90U1F2)
PROPYLENE GLYCOL MONOLAURATE (UNII: 668Z5835Z3)
HYPROMELLOSE 2208 (15000 MPA.S) |
